GSE112983
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist
We report differential expressed genes in HepG2 cells treated with control, E2, or an ER agonist Overall design: Methods: HepG2 cells treated with control, E2, PPT, or DPN for 48 hours. mRNA profiles were generated by deep sequencing, in triplicates, using Illumina NextSeq2000 sequencing system.  The sequence reads that passed quality filters were analyzed at the transcript level with DESeq2.